Register now for a personalized educational experience.
Already a member? Log In
By linking my Doximity account with UPMC Physician Resources, I acknowledge that:
Forgot your password? Enter the email address you used to create your account to initiate a password reset.
Dr. Ramon Bataller reviews the predicting factors of alcoholic liver disease, and identifies current therapeutic options and management of alcoholic hepatitis.
Upon completion of this activity, participants should be able to:
Dr. Bataller has reported no relevant relationships with entities producing health care goods or services.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (.05) continuing education units (CEU) which are equivalent to .50 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 8/23/2018 | Last Modified On: 8/23/2018 | Expires: 8/23/2019
Altamirano J, Miquel R, Katoonizadeh A, Albraides JG, Duarte-Rojo A, Louvet A, Agustin S, Mookerjee RP, Michelena J, Smyrk TC, Buob M, Leteurtre E, Rincon D, Ruiz P, Garcia-Pagan JC, Guerrero-Marquez G, Jones PD, Barritt IV AS, Arroyo V, Bruguera M, Banares R, Gines P, Caballeria J, Roskams T, Nevens F, Jalan R, Mathurin P, Shah VH, Bataller R. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014; 146: 1231-9.
Singal A, Bataller R, Ahn J, Kamath P, Shah VH, Ashwani K. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018; 113: 175–94.
Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, Downs N, Gleeson D, MacGilchrist A, Grant A, Hood S. Prednisone or pentoxifyline for alcoholic hepatitis. New Engl J Med. 2015; 372: 1619-28.